$NGVT

Li David H sold $762K of NGVT

Li David H (President & CEO) sold 10,000 shares of Ingevity Corp (NGVT) at an average of $76.18 ($75.73–$76.62, $0.76M total) across 2 trades over 2026-08-12 to 2026-08-13 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Li David H
Published Aug 14, 2026, 9:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 11:52 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$NGVT
Neutral
high confidence
Mentioned
$NGVT
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NGVTNeutralLow
01

Why it matters

The only new information is the disclosed sale size, dates, and price range under a pre-arranged 10b5-1 plan; there is no mention of earnings, guidance, litigation, or business developments.

02

Market read

Traders may briefly reassess sentiment around insider behavior, but the 10b5-1 structure and lack of fundamental updates suggest limited trading edge.

03

What to watch

The article does not state whether sales were part of a larger scheduled program or whether there were concurrent purchases, so the net insider posture is incomplete.

Relevance 4/10Novelty 3/10Timing: filed on 2026-08-14 after Aug 12-13 sales

Background

The article is an SEC Form 4 insider transaction disclosure for Ingevity (NGVT) by its President and CEO, Li David H.

Company-level read

Ticker impact

$NGVTNeutralHigh confidence
Context

Ingevity CEO Li David H sold about 10,000 shares in Aug 12-13 under a 10b5-1 plan, worth about $761,750.

Expected impact

Likely limited near-term impact; any reaction should be muted unless paired with other new disclosures.

Evidence & confidence

The filing is a Form 4 insider transaction with explicit 10b5-1 pre-arrangement and no accompanying operational or financial guidance changes in the text.

Market effects

No sector-level signal is provided; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Insider sales can be purely liquidity-driven even when they look bearish; the 10b5-1 flag reduces interpretive weight.

Key entities

  • Ingevity Corp

    Subject of the Form 4 insider sale disclosure.

  • Li David H

    President and CEO who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NGVTMedAI 8/10

Ingevity (NGVT) Q2 2026 Earnings Call Transcript

Ingevity (NGVT) held its Q2 2026 earnings call. Net sales were $314 million, down 5% on reported basis due to the Road Markings divestiture. Adjusted EBITDA rose 14% to $115 million, with margin at 36.6%. Adjusted EPS was $1.74. Free cash flow was $89 million. Full-year guidance for EBITDA and EPS was raised.

$NGVTMedAI 8/10

Ingevity Q2 Earnings Call Highlights

Ingevity (NYSE:NGVT) reported Q2 cash flow excluding a litigation settlement of about $89M, or $2.52/share, with capex near $10M. Performance Materials sales rose 4% to $161M, with segment EBITDA up 6% to $86M and margin to 53.6%. The company raised 2026 outlook to adjusted EBITDA $380M-$400M and EPS $5.00-$5.45, plus free cash flow $220M-$245M.

$NGVTMed

Ingevity Corp (NGVT): Results of Operations and Financial Condition

Ingevity Corp (NGVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Ingevity reports second quarter 2026 financial results Second Quarter 2026 Results and Recent Highlights: • Net sales of $314.1 million decreased 5% from prior year; exc